United States of America allocated pharmaceutical companies with Novavax of $1,6 billion for production vaccines from Koronavirus

Chicago (information agency "Reuters") - the American authorities allocated pharmaceutical companies with Novavax Inc $1,6 billion for a covering of expenses on tests, commercialization and production a potential vaccine from Koronavirus to United States of America on purpose deliveries 100 million doses by January, 2021. The stocks Novavax jumped up for 35% at the off-exchange auctions. The allocated sum became the largest within the program of the White house of Operation Warp Speed, urged to accelerate receiving access to vaccines and preparations for fight with Koronavirus ". These means of Warp Speed will pay production 100 million doses (vaccine) which will be delivered beginning...